Hill Dermaceuticals, Inc.® Opens an Alternate Facility

Sanford, Florida, January 09, 2017 –

Hill Dermaceuticals, Inc®, a privately held pharmaceutical company with 6 NDAs and that develops and manufactures prescription drugs focusing on Dermatologic diseases, announced the opening of its second location.  Hill’s new facility houses both offices, and alternate manufacturing suites for future projects.